Information Technology
iotaMotion Announces First Use of Robotic-Assisted Cochlear Implant Technology Outside the U.S. as Part of Clinical Investigation in Switzerland
Professor Huber highlighted the significance of the collaboration: "Bringing this new robotic-assisted technology for cochlear implantation to University of Zurich was extremely important to our team. It will enable us to continue to advance cochlear implant care and explore techniques that have never been used clinically prior to this study."
The study leverages robotic control of the array insertion to analyze the relationship between electrode insertion dynamics and cochlear function, as measured by ECochG signals. This approach may pave the way for future advancements in cochlear implant programming and hearing preservation strategies.
"This represents a major milestone for iotaMotion as we expand outside of the United States with our technology," said Mike Lobinsky , President & CEO of iotaMotion. "The team in Zurich has been an exceptional partner, and we look forward to continuing our relationship."
While currently under pre-market clinical investigation, wider availability of the iotaSOFT Insertion System is planned for 2026.
iotaMotion, Inc. is a medical technology company based in St. Paul, MN , dedicated to advancing cochlear implant surgery beyond human capability through robotic-assisted solutions. Its flagship technology, the iotaSOFT Insertion System, is designed to provide a slow and consistent electrode array insertion that is designed to preserve delicate intracochlear structures. The system is commercially available in the United States and under clinical investigation in other global markets.
For more information, visit www.iotamotion.com or contact Wade Colburn , Vice President of Marketing and Clinical, at pr@iotamotion.com.
Logo - https://mma.prnewswire.com/media/545464/5316339/iotaMotion_Inc___Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/iotamotion-announces-first-use-of-robotic-assisted-cochlear-implant-technology-outside-the-us-as-part-of-clinical-investigation-in-switzerland-302454131.html